Overview Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions Status: Completed Trial end date: 2006-07-01 Target enrollment: Participant gender: Summary The purpose of this study is to demonstrate the relative bioequivalence of Eplerenone 50 mg Tablets Under Fed Conditions. Phase: Phase 1 Details Lead Sponsor: SandozTreatments: EplerenoneSpironolactone